Dr. Julius Middleton Wilder, MD, PhD

Dr. Wilder practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Wilder's NPI, 1598924995, was assigned on June 2, 2008. Dr. Wilder graduated from Duke University School of Medicine in 2008. Dr. Wilder holds North Carolina license 149237.

Dr. Wilder's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Wilder's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. Dr. Wilder is also affiliated with Duke Regional Hospital. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Wilder to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wilder practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Wilder's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Wilder is licensed in North Carolina.

CMS data shows 231 Medicare services from Dr. Wilder across 7 procedure codes in 2024, for 183 Medicare patients. Medicare paid $21,825 for them.

CMS counts 183 Medicare patients who saw Dr. Wilder in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wilder's median patient age at 69, with 58% women.

In 2024, Dr. Wilder wrote 228 Medicare Part D claims for 108 patients. 89% of them were for generic drugs. CMS names the drug for 139 of them, across 7 drugs with 11 or more claims each, at $3,762 in total drug cost. In 2023, CMS named 78 claims across 4 drugs.

Dr. Wilder accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wilder as offering telehealth. CMS counts 48 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Wilder, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 37 papers to Dr. Wilder, published from 2013 to 2024. 2021 was the busiest year, with 6. The most frequent topics are Healthcare Disparities, Health Services Accessibility and Hepatitis C. Dr. Wilder has published most often in Hepatology. Dr. Wilder's most frequent co-authors are Andrew Joseph Muir, MD, Yuval Adrash Dinesh Patel, MD and Jacqueline B. Henson, MD.

Dmand AI links Dr. Wilder to 1 clinical trial. Conditions studied include Hepatitis C, Chronic and Hepatitis, Chronic. Open Payments lists research payments to Dr. Wilder that name 1 trial.

CMS Open Payments shows 127 general payments to Dr. Wilder from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $47,820. It also lists 91 research payments totaling $35,038 from 2018 to 2025, naming 1 clinical trial.

Dr. Wilder graduated from Duke University School of Medicine in 2008.